Schedule 13G ownership disclosure
REDHILL BIOPHARMA LTD
Security class unavailable · CUSIP: 757468202
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 647,824
- Percent of class
- 3.1900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-24-000071
- Form type
- SC 13G
- Filer
- Empery Asset Management, LP
- CIK
- CIK 1469336
- Filed
- Jan 08, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership